Facebook
Instagram
Linkedin
Pinterest
Reddit
Twitter
Youtube
Sign in
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Put Your School on the Map
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Terms and Conditions
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Put Your School on the Map
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Emerging Therapy
Emerging Therapy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Intestinal Protein Linked to the Development of Food Allergies
Dave Bloom
-
2025/01/24
Nasal Emergency Epinephrine Alternative Shows Positive Topline Data in Clinical Study
DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study
DBV Confirms Alignment with FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1-3 Years-Old
Dr Edwin Kim Receives $1-Million Grant for Novel Multi-Nut Allergy SLIT Treatment Study
FDA Approves LongBio’s Anti-IgE Antibody for Clinical Trials to Treat Food...
News Wire ~ 3rd Party Press Release
-
2024/11/27
0
Aravax Testing New Way to Tackle Food Allergy
News Wire ~ 3rd Party Press Release
-
2024/11/15
0
Are Biologics the Future of Food Allergy Treatment? One Study Weighs...
News Wire ~ 3rd Party Press Release
-
2024/11/04
0
Aquestive Announces Positive Topline Results from Study of Sublingual Epinephrine Film...
Dave Bloom
-
2024/10/25
0
DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the...
News Wire ~ 3rd Party Press Release
-
2024/10/23
0
New Phase 1 Study in Peanut Allergy Recruiting Now in Australia
News Wire ~ 3rd Party Press Release
-
2024/10/15
0
A Conversation About Sublingual Epinephrine
Dave Bloom
-
2024/09/10
0
Nanoparticles Delivered to Mice Block Alpha-Gal Reactions
News Wire ~ 3rd Party Press Release
-
2024/08/14
0
Granted US Patent for Bioactive Delivery Platform, BioVaxys Signs Agreement to...
Dave Bloom
-
2024/07/29
0
First Human Trials of IgGenix Peanut Allergy Treatment to Begin in...
Dave Bloom
-
2024/07/18
0
1
2
3
...
28
Page 1 of 28